M. Frandsen

1.6k total citations
20 papers, 1.3k citations indexed

About

M. Frandsen is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Physiology. According to data from OpenAlex, M. Frandsen has authored 20 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Endocrinology, Diabetes and Metabolism, 5 papers in Molecular Biology and 5 papers in Physiology. Recurrent topics in M. Frandsen's work include Diabetes, Cardiovascular Risks, and Lipoproteins (8 papers), Diabetes Treatment and Management (7 papers) and Diabetes Management and Research (6 papers). M. Frandsen is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (8 papers), Diabetes Treatment and Management (7 papers) and Diabetes Management and Research (6 papers). M. Frandsen collaborates with scholars based in Denmark, Sweden and Netherlands. M. Frandsen's co-authors include H.‐H. Parving, Jens Sandahl Christiansen, Jens Gammelgaard, Lene Ringholm, Pia Ekbom, Peter Damm, Charlotte Glümer, Elisabeth R. Mathiesen, Dorte Møller Jensen and Søren S. Lund and has published in prestigious journals such as The Lancet, PLoS ONE and Diabetes Care.

In The Last Decade

M. Frandsen

19 papers receiving 1.2k citations

Peers

Countries citing papers authored by M. Frandsen

Since Specialization

Citations

This map shows the geographic impact of M. Frandsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Frandsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Frandsen more than expected).

Fields of papers citing papers by M. Frandsen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Frandsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Frandsen. The network helps show where M. Frandsen may publish in the future.

Co-authorship network of co-authors of M. Frandsen

This figure shows the co-authorship network connecting the top 25 collaborators of M. Frandsen. A scholar is included among the top collaborators of M. Frandsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Frandsen. M. Frandsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Total Mortality by Elevated Transferrin Saturation in Patients With Diabetes 2013 ·Diabetes Care ·Christina Ellervik, Henrik U. Andersen, Anne Tybjærg‐Hansen, M. Frandsen, Henrik Birgens, Børge G. Nordestgaard, Thomas Mandrup‐Poulsen	13
2	Elevated Transferrin Saturation and Risk of Diabetes 2011 ·Diabetes Care ·Christina Ellervik, Thomas Mandrup‐Poulsen, Henrik U. Andersen, Anne Tybjærg‐Hansen, M. Frandsen, Henrik Birgens, Børge G. Nordestgaard	56
3	Impact of metformin versus the prandial insulin secretagogue, repaglinide, on fasting and postprandial glucose and lipid responses in non-obese patients with type 2 diabetes 2011 ·European Journal of Endocrinology ·Søren S. Lund, Lise Tarnow, M. Frandsen, U. Smidt, Oluf Pedersen, Hans‐Henrik Parving, Allan Vaag	0
4	Agreement Between Fasting and Postprandial LDL Cholesterol Measured with 3 Methods in Patients with Type 2 Diabetes Mellitus 2010 ·Clinical Chemistry ·Søren S. Lund, Martin Petersen, M. Frandsen, U. Smidt, Hans‐Henrik Parving, Allan Vaag, Tonny Jensen	14
5	Combining insulin with metformin or an insulin secretagogue in non-obese patients with type 2 diabetes: 12 month, randomised, double blind trial 2009 ·BMJ ·Søren S. Lund, Lise Tarnow, M. Frandsen, (unknown), Birgitte V. Hansen, Oluf Pedersen, (unknown), Allan Vaag	32
6	Effect of adjunct metformin treatment on levels of plasma lipids in patients with type 1 diabetes 2009 ·Diabetes Obesity and Metabolism ·Søren S. Lund, Lise Tarnow, Anne Sofie Astrup, Peter Hovind, Peter Karl Jacobsen, Amra Ciric Alibegovic, (unknown), Lotte Pietraszek, M. Frandsen, Peter Rossing, H.‐H. Parving, Allan Vaag	41
7	Sustained postprandial decrease in plasma levels of LDL cholesterol in patients with type‐2 diabetes mellitus 2008 ·Scandinavian Journal of Clinical and Laboratory Investigation ·Søren S. Lund, M B Petersen, M. Frandsen, U. Smidt, H.‐H. Parving, Allan Vaag, T. Jensen	10
8	Impact of metformin versus repaglinide on non-glycaemic cardiovascular risk markers related to inflammation and endothelial dysfunction in non-obese patients with type 2 diabetes 2008 ·European Journal of Endocrinology ·Søren S. Lund, Lise Tarnow, Coen D.A. Stehouwer, Casper G. Schalkwijk, Tom Teerlink, Jørgen Gram, K. Winther, M. Frandsen, U. Smidt, Oluf Pedersen, Hans‐Henrik Parving, Allan Vaag	78
9	Effect of Adjunct Metformin Treatment in Patients with Type-1 Diabetes and Persistent Inadequate Glycaemic Control. A Randomized Study 2008 ·PLoS ONE ·Søren S. Lund, Lise Tarnow, Anne Sofie Astrup, Peter Hovind, Peter Karl Jacobsen, Amra Ciric Alibegovic, (unknown), Lotte Pietraszek, M. Frandsen, Peter Rossing, Hans‐Henrik Parving, Allan Vaag	70
10	Impact of metformin versus the prandial insulin secretagogue, repaglinide, on fasting and postprandial glucose and lipid responses in non-obese patients with type 2 diabetes 2008 ·European Journal of Endocrinology ·Søren S. Lund, Lise Tarnow, M. Frandsen, U. Smidt, Oluf Pedersen, Hans‐Henrik Parving, Allan Vaag	3
11	Impact of metformin versus the prandial insulin secretagogue, repaglinide, on fasting and postprandial glucose and lipid responses in non-obese patients with type 2 diabetes 2008 ·European Journal of Endocrinology ·Søren S. Lund, Lise Tarnow, M. Frandsen, U. Smidt, Oluf Pedersen, Hans‐Henrik Parving, Allan Vaag	26
12	Targeting hyperglycaemia with either metformin or repaglinide in non‐obese patients with type 2 diabetes: results from a randomized crossover trial 2007 ·Diabetes Obesity and Metabolism ·Søren S. Lund, Lise Tarnow, Coen D.A. Stehouwer, Casper G. Schalkwijk, M. Frandsen, U. Smidt, Oluf Pedersen, H.‐H. Parving, Allan Vaag	37
13	HbA1c Levels Are Significantly Lower in Early and Late Pregnancy 2004 ·Diabetes Care ·Lene Ringholm, Pia Ekbom, Peter Damm, Charlotte Glümer, M. Frandsen, Dorte Møller Jensen, Elisabeth R. Mathiesen	251
14	Comparison of a Homogeneous Assay With a Precipitation Method for the Measurement of HDL Cholesterol in Diabetic Patients 2002 ·Diabetes Care ·Tonny Jensen, (unknown), M. Frandsen, Bo Dinesen, Steen Stender	12
15	Prevalence of hereditary haemochromatosis in late-onset type 1 diabetes mellitus: a retrospective study 2001 ·The Lancet ·Christina Ellervik, Thomas Mandrup‐Poulsen, Børge G. Nordestgaard, (unknown), Merete Appleyard, M. Frandsen, Pia S. Petersen, P. Schlichting, Torben Særmark, Anne Tybjærg‐Hansen, Henrik Birgens	96
16	Kidney function and size in type 1 (insulin-dependent) diabetic patients before and during growth hormone administration for one week 1982 ·Diabetologia ·John Christiansen, Jens Gammelgaard, M. Frandsen, (unknown), H.‐H. Parving	57
17	Effect of intravenous glucose infusion on renal function in normal man and in insulin-dependent diabetics 1981 ·Diabetologia ·Jens Sandahl Christiansen, M. Frandsen, H.‐H. Parving	108
18	The effect of intravenous insulin infusion on kidney function in insulin-dependent diabetes mellitus 1981 ·Diabetologia ·Jens Sandahl Christiansen, M. Frandsen, H.‐H. Parving	74
19	Increased kidney size, glomerular filtration rate and renal plasma flow in short-term insulin-dependent diabetics 1981 ·Diabetologia ·Jens Sandahl Christiansen, Jens Gammelgaard, M. Frandsen, H.‐H. Parving	272
20	An artificial betacell: assessment of the glucose analyser, infusion system and optimization of constants for the algorithms 1981 ·Scandinavian Journal of Clinical and Laboratory Investigation ·Jens Sandahl Christiansen, Per Svendsen, (unknown), M. Frandsen, E. R. Mathiesen, Kristian Hillert Winther, T. Deckert	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact